Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4648110
Max Phase: Preclinical
Molecular Formula: C34H53NO2
Molecular Weight: 507.80
Molecule Type: Unknown
Associated Items:
ID: ALA4648110
Max Phase: Preclinical
Molecular Formula: C34H53NO2
Molecular Weight: 507.80
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](CCCNCc1ccccc1)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C
Standard InChI: InChI=1S/C34H53NO2/c1-23(11-10-20-35-22-24-12-8-7-9-13-24)25-18-19-32(4)28-16-14-26-27(15-17-29(36)31(26,2)3)34(28,6)30(37)21-33(25,32)5/h7-9,12-14,23,25,27-30,35-37H,10-11,15-22H2,1-6H3/t23-,25-,27-,28+,29+,30-,32+,33-,34+/m1/s1
Standard InChI Key: JAMPNBVMBIYBGJ-JFAMYKFUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 507.80 | Molecular Weight (Monoisotopic): 507.4076 | AlogP: 7.13 | #Rotatable Bonds: 7 |
Polar Surface Area: 52.49 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 9.64 | CX LogP: 6.36 | CX LogD: 4.16 |
Aromatic Rings: 1 | Heavy Atoms: 37 | QED Weighted: 0.27 | Np Likeness Score: 2.27 |
1. Wang J, Liu J, Xie Z, Li J, Li J, Hu L.. (2020) Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators., 30 (2): [PMID:31744674] [10.1016/j.bmcl.2019.126790] |
Source(1):